Back

Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.

21 April 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiovascular pharmacology Pharmacology and Pharmacotherapy, Other EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Antonio Aurelio Rojas Sanchez

Regional University Hospital Carlos Haya, Malaga (Spain)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Lukina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Professor I. Parepa (Constanta, RO)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Cardiovascular pharmacology

The Event

Event poster

EuroPrevent 2018

21 April 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Inflammatory risk in patients with coronary artery disease: the impact of cardiac rehabilitation and association to cardiorespiratory fitness
23 April 2026
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial
29 August 2022
thumbnail
Webinar
Exercise, rehabilitation and preventive strategies in cardio-oncology
3 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources